U.S. Sen. Herb Kohl is exploring a national registry to require public disclosure of drug company payments to physicians.
“We need transparency,” said the Wisconsin Democrat at the first of a series of hearings on Wednesday as chairman of the Special Committee on Aging. The hearings are to explore the financial ties between the pharmaceutical industry and doctors, which critics say create the appearance of inappropriate influence on patient treatment and the drugs prescribed.